Sitemap

Presserum

Mölndal, Sverige (marts 2010). Astra Tech, førende leverandør af omfattende løsninger til dental implantatbehandling, er glad for at kunne meddele, at Atlantis™ Abutment-løsninger bliver udvidet til at omfatte implantaterne NobelActive™ NP 3.5 og RP 4.3, 5.0 til europæiske og australske kunder. 

Astra Tech tilbyder patientspecifikke abutments i fire forskellige materialer, nemlig titanium, guldfarvet titanium, hvid zirconia og farvet zirconia. 

Ved at tilbyde Atlantis Abutments til NobelActive™-implantater forstærker Astra Tech sin førerposition inden for levering af patientspecifikke abutments til alle større implantatsystemer. Denne lancering er den seneste i en række Atlantis Abutments, der er ved at blive udviklet til nye implantatgrænseflader, for eksempel Straumann™ Bone Level-implantater. Astra Tech har planer om at lancere yderligere grænseflader og materialevalg for den patientspecifikke Atlantis™-løsning i 2010.

The five-year follow-up study on OsseoSpeed™ implants confirms the successful results presented in previous studies.

The five-year follow-up study was made by Dr. Steveling and co-workers at the Department of Oral and Maxillofacial Surgery at the Heidelberg University in Germany. The conclusion is that the OsseoSpeed™ implant shows very good results also in compromised sites when using an early loading protocol.

Astra Tech, a market leader in the field of implant dentistry, announces their strategic alliance with Dental Wings, the Canadian-based provider of CAD/CAM solutions with specialized development of 3D scanners, beginning in early 2010. As a result, Dental Wings users worldwide will have the ability to remotely transfer scans to Astra Tech’s design and manufacturing centers for the production of Atlantis™ patient-specific abutments for all major implant systems.

The Swedish medical device company Astra Tech, a subsidiary of AstraZeneca, continues expanding on the dental implant market by acquiring its Japanese distributor, Denics International Co. Ltd., with revenues of USD 30 million in 2006.

3M ESPE and Astra Tech AB, a leader and innovator in the dental implant industry, announce a global partnership to provide Astra Tech’s Atlantis™ patient-specific abutments to 3M ESPE Lava™ customers. The two companies have developed an interface which will enable the Lava™ Scan ST Design System to communicate directly with Astra Tech’s Atlantis technology.

“Follow-up research among patients consistently shows a marginal bone level reduction of just 0.4 mm or less for Astra Tech dental implants, a performance indicator at least three times superior to the industry norm. The findings involve hundreds of individual cases and are remarkable in their consistency,” says Lyndon Cooper, Professor of Dentistry in the Department of Prosthodontics at the University of North Carolina, who has performed one of the studies.

Astra Tech challenges the current standard in marginal bone maintenance and sets a new standard implying only 0.3 mm of bone loss for a successful implant. Also, Astra Tech launches Atlantis™, a unique method of producing patient-specific abutments based on the appearance of the final tooth, in Europe.

The Swedish medical technology company Astra Tech AB, a subsidiary of AstraZeneca, is purchasing the US dental company Atlantis Components Inc. for USD 71 million in cash (approx. SEK 500 million). This business deal is part of Astra Tech’s growth strategy.